Hall, Amy Jennae,Bland, Jeff,Konda, Veera,Pacioretty, Linda,Tripp, Matthew L.,Babish, John G.
申请号：
AU2012261769
公开号：
AU2012261769A1
申请日:
2012.12.14
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
#$%^&*AU2012261769A120130124.pdf#####C:\NRIPoroUJLC\JARW16456 I DULC-14f12/I2 ABSTRACT Disclosed are botanically based compositions and methods useful for the treatment of metabolic syndrome and diabetes type 2. Compositions, kits, and methods are additionally disclosed for means to augment the activity of identified glucose and insulin regulating drugs. Hexahydrocolupulone 1 .- 0.!57 Spent Hops rom,commmm e 1.1 Beta-Acids Leavtrvasimmi t 1.24 Alpha Acids rwn.: n mm t 1.45 Xanthohumol rLrizwa teThI 1.46 Hexahydroisoalpha acids umam. _i__ essa 1_ rL( Tetrahydroisoalpha acids La4 w1t. aL_1.79 Rho-isoalpha acids 2..%rrtn : maairnu.-rwwaavam o--+-- 2.25 Isoalpha acids b m mla aim: 2.45 Indomethacin mmmuna____ .r:= 1.33 Troglitazone 745-.J -A14 Solvent Control r:- 2t. 1.00 0.00 0,50 1.00 1.50 2.00 2.50 3.00 Relative Nonpolar Lipid Content
